Cook Medical launches advanced platform lead extraction technologies
Devices help electrophysiologists and cardiac surgeons achieve greater precision, stability and control when removing cardiac leads
Cook Medical has launched four advanced platform lead extraction technologies.
The devices are designed to enable electrophysiologists and cardiac surgeons across Europe to achieve greater precision, stability and control when removing cardiac leads.
Among the new technologies are the enhanced Evolution sheath sets, the Evolution RL and the Evolution Shortie RL. The new sets now include a bi-rotational sheath, a low profile, decagonal tip and a responsive, contoured handle.
Cook has also launched its SteadySheath, a new specialised outer sheath designed to help cardiac specialists minimise vessel movement and disrupt challenging adhesions associated with chronically-implanted cardiac leads.
Finally, the One-Tie accessory is specifically designed to bind the lead, cables and coil to Cook’s Liberator Locking Stylet.
In the UK, these Advanced Platform lead extraction devices are already being trialled at a number of leading cardiac centres. This includes Manchester Heart Centre at the Manchester Royal Infirmary (MRI).
Dr Amir Zaidi, consultant cardiologist at the MRI, said: “The need for cardiac device lead extraction is growing rapidly due to increasing rates of infection and lead failures. Although extraction tools have increased the safety of extraction, there remains a significant risk of death or serious complications.
“Cook’s Advanced Platform technologies have given us greater control in the operating room to allow us to extract leads more safely. We extract up to 300 leads so any techniques or devices that can help us to enhance our procedures are most welcome.”
Lou Goode, global leader of Cook’s lead management business unit, added: “We acknowledge that lead extraction is a very complex surgical procedure that requires precision and technique. We have improved our advanced platform technologies to provide our clinician users with the tools they need to feel even more in control. We hope to enhance the treatment of more and more patients with these enhanced technologies.”